267 related articles for article (PubMed ID: 15529385)
1. Enhancement of collagen-induced arthritis in mice genetically deficient in extracellular superoxide dismutase.
Ross AD; Banda NK; Muggli M; Arend WP
Arthritis Rheum; 2004 Nov; 50(11):3702-11. PubMed ID: 15529385
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of effects of complement inhibition in murine collagen-induced arthritis.
Banda NK; Kraus D; Vondracek A; Huynh LH; Bendele A; Holers VM; Arend WP
Arthritis Rheum; 2002 Nov; 46(11):3065-75. PubMed ID: 12428251
[TBL] [Abstract][Full Text] [Related]
3. Interferon-gamma regulates susceptibility to collagen-induced arthritis through suppression of interleukin-17.
Chu CQ; Swart D; Alcorn D; Tocker J; Elkon KB
Arthritis Rheum; 2007 Apr; 56(4):1145-51. PubMed ID: 17393396
[TBL] [Abstract][Full Text] [Related]
4. Increased production of intracellular interleukin-1 receptor antagonist type I in the synovium of mice with collagen-induced arthritis: a possible role in the resolution of arthritis.
Gabay C; Marinova-Mutafchieva L; Williams RO; Gigley JP; Butler DM; Feldmann M; Arend WP
Arthritis Rheum; 2001 Feb; 44(2):451-62. PubMed ID: 11229477
[TBL] [Abstract][Full Text] [Related]
5. An opposing time-dependent immune-modulating effect of the sympathetic nervous system conferred by altering the cytokine profile in the local lymph nodes and spleen of mice with type II collagen-induced arthritis.
Härle P; Möbius D; Carr DJ; Schölmerich J; Straub RH
Arthritis Rheum; 2005 Apr; 52(4):1305-13. PubMed ID: 15818682
[TBL] [Abstract][Full Text] [Related]
6. Enhanced Th1 and Th17 responses and arthritis severity in mice with a deficiency of myeloid cell-specific interleukin-1 receptor antagonist.
Lamacchia C; Palmer G; Seemayer CA; Talabot-Ayer D; Gabay C
Arthritis Rheum; 2010 Feb; 62(2):452-62. PubMed ID: 20112392
[TBL] [Abstract][Full Text] [Related]
7. Immunoregulatory effects of allogeneic mixed chimerism induced by nonmyeloablative bone marrow transplantation on chronic inflammatory arthritis and autoimmunity in interleukin-1 receptor antagonist-deficient mice.
Cho SG; Min SY; Park MJ; Lee KW; Cho YG; Cho ML; Chang HS; Park SH; Lee JW; Min WS; Kim CC; Kim HY
Arthritis Rheum; 2006 Jun; 54(6):1878-87. PubMed ID: 16736524
[TBL] [Abstract][Full Text] [Related]
8. Blockade of the interleukin-21/interleukin-21 receptor pathway ameliorates disease in animal models of rheumatoid arthritis.
Young DA; Hegen M; Ma HL; Whitters MJ; Albert LM; Lowe L; Senices M; Wu PW; Sibley B; Leathurby Y; Brown TP; Nickerson-Nutter C; Keith JC; Collins M
Arthritis Rheum; 2007 Apr; 56(4):1152-63. PubMed ID: 17393408
[TBL] [Abstract][Full Text] [Related]
9. Amelioration of collagen-induced arthritis and suppression of interferon-gamma, interleukin-12, and tumor necrosis factor alpha production by interferon-beta gene therapy.
Triantaphyllopoulos KA; Williams RO; Tailor H; Chernajovsky Y
Arthritis Rheum; 1999 Jan; 42(1):90-9. PubMed ID: 9920019
[TBL] [Abstract][Full Text] [Related]
10. Arthritis in mice that are deficient in interleukin-1 receptor antagonist is dependent on genetic background.
Zhou F; He X; Iwakura Y; Horai R; Stuart JM
Arthritis Rheum; 2005 Dec; 52(12):3731-8. PubMed ID: 16320323
[TBL] [Abstract][Full Text] [Related]
11. Acceleration of the onset of collagen-induced arthritis by a deficiency of platelet endothelial cell adhesion molecule 1.
Tada Y; Koarada S; Morito F; Ushiyama O; Haruta Y; Kanegae F; Ohta A; Ho A; Mak TW; Nagasawa K
Arthritis Rheum; 2003 Nov; 48(11):3280-90. PubMed ID: 14613294
[TBL] [Abstract][Full Text] [Related]
12. Synergistic effect on the attenuation of collagen induced arthritis in tumor necrosis factor receptor I (TNFRI) and interleukin 6 double knockout mice.
Yamaguchi N; Ohshima S; Umeshita-Sasai M; Nishioka K; Kobayashi H; Mima T; Kishimoto T; Saeki Y
J Rheumatol; 2003 Jan; 30(1):22-7. PubMed ID: 12508385
[TBL] [Abstract][Full Text] [Related]
13. Oxidative status of DBA/1J mice with type II collagen-induced arthritis.
Choi EM
J Appl Toxicol; 2007; 27(5):472-81. PubMed ID: 17299831
[TBL] [Abstract][Full Text] [Related]
14. Enhanced osteoclast development in collagen-induced arthritis in interferon-gamma receptor knock-out mice as related to increased splenic CD11b+ myelopoiesis.
De Klerck B; Carpentier I; Lories RJ; Habraken Y; Piette J; Carmeliet G; Beyaert R; Billiau A; Matthys P
Arthritis Res Ther; 2004; 6(3):R220-31. PubMed ID: 15142268
[TBL] [Abstract][Full Text] [Related]
15. Involvement of lymphocytes with a Th1 cytokine profile in bone cell damage associated with MMP-9 production in collagen-induced arthritis.
Chen J; Zhang XM; Xu Q
Inflamm Res; 2004 Dec; 53(12):670-9. PubMed ID: 15654515
[TBL] [Abstract][Full Text] [Related]
16. THR0921, a novel peroxisome proliferator-activated receptor gamma agonist, reduces the severity of collagen-induced arthritis.
Tomita T; Kakiuchi Y; Tsao PS
Arthritis Res Ther; 2006; 8(1):R7. PubMed ID: 16356194
[TBL] [Abstract][Full Text] [Related]
17. Reduction in the evolution of murine type II collagen-induced arthritis by treatment with rosiglitazone, a ligand of the peroxisome proliferator-activated receptor gamma.
Cuzzocrea S; Mazzon E; Dugo L; Patel NS; Serraino I; Di Paola R; Genovese T; Britti D; De Maio M; Caputi AP; Thiemermann C
Arthritis Rheum; 2003 Dec; 48(12):3544-56. PubMed ID: 14674008
[TBL] [Abstract][Full Text] [Related]
18. Severity of murine collagen-induced arthritis correlates with increased CYP7B activity: enhancement of dehydroepiandrosterone metabolism by interleukin-1beta.
Dulos J; Verbraak E; Bagchus WM; Boots AM; Kaptein A
Arthritis Rheum; 2004 Oct; 50(10):3346-53. PubMed ID: 15476247
[TBL] [Abstract][Full Text] [Related]
19. Anti-type II collagen antibody accelerates arthritis via CXCR2-expressing cells in IL-1 receptor antagonist-deficient mice.
Kagari T; Tanaka D; Doi H; Iwakura Y; Shimozato T
Eur J Immunol; 2007 Oct; 37(10):2753-63. PubMed ID: 17823985
[TBL] [Abstract][Full Text] [Related]
20. Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice: a comparative study using anti-TNFalpha, anti-IL-1alpha/beta and IL-1Ra.
Joosten LA; Helsen MM; van de Loo FA; van den Berg WB
Arthritis Rheum; 2008 Feb; 58(2 Suppl):S110-22. PubMed ID: 18240201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
